Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

3 companies

Swedencare

Market Cap: SEK 3.6b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 22.20

1.6%

-43.9%

Cantargia

Market Cap: SEK 487.3m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.96

12.1%

-26.7%

Sprint Bioscience

Market Cap: SEK 338.7m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.21

-2.4%

471.2%